HEADER HYDROLASE 27-JAN-07 2OP9 TITLE SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF TITLE 2 INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE COMPND 3 PROTEINASE (3CL-PRO, 3CLP); COMPND 4 CHAIN: A, B; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_TAXID: 227859; SOURCE 4 STRAIN: TOR2; SOURCE 5 GENE: 3CLPRO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30XA KEYWDS SARS, 3CLPRO, PROTEINASE, PROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.S.CRAIK,D.H.GOETZ REVDAT 6 25-DEC-24 2OP9 1 REMARK LINK REVDAT 5 27-DEC-23 2OP9 1 REMARK SEQADV LINK REVDAT 4 24-JAN-18 2OP9 1 REMARK REVDAT 3 24-FEB-09 2OP9 1 VERSN REVDAT 2 14-AUG-07 2OP9 1 JRNL REVDAT 1 17-JUL-07 2OP9 0 JRNL AUTH D.H.GOETZ,Y.CHOE,E.HANSELL,Y.T.CHEN,M.MCDOWELL,C.B.JONSSON, JRNL AUTH 2 W.R.ROUSH,J.MCKERROW,C.S.CRAIK JRNL TITL SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW JRNL TITL 2 CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS JRNL TITL 3 CORONAVIRUS. JRNL REF BIOCHEMISTRY V. 46 8744 2007 JRNL REFN ISSN 0006-2960 JRNL PMID 17605471 JRNL DOI 10.1021/BI0621415 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 59985 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2998 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4060 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2030 REMARK 3 BIN FREE R VALUE SET COUNT : 190 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 491 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.40000 REMARK 3 B22 (A**2) : 0.63000 REMARK 3 B33 (A**2) : -1.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.07000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.115 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.468 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4812 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3171 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6528 ; 1.544 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7730 ; 3.328 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 597 ;12.196 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 212 ;35.019 ;24.245 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 769 ;15.225 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;13.540 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 734 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5387 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 995 ; 0.007 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1058 ; 0.233 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3402 ; 0.234 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2428 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2410 ; 0.100 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 341 ; 0.193 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 26 ; 0.294 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 70 ; 0.359 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.221 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3042 ; 1.193 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1224 ; 0.226 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4808 ; 1.798 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1982 ; 2.717 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1720 ; 4.028 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041417. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60036 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 65.938 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG-6K, 10% DMSO, 2MM DTT, 0.1M REMARK 280 MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.39900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ACTIVE BIOLOGICAL UNIT IS A HOMODIMER AS SEEN IN THE REMARK 300 ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 0 REMARK 465 ALA B 46 REMARK 465 ASP B 155 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 LEU A 50 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SD MET A 130 O HOH A 762 1.51 REMARK 500 CE MET A 130 O HOH A 762 1.76 REMARK 500 CG MET A 130 O HOH A 762 1.82 REMARK 500 SG CYS B 145 C2 WR1 B 602 1.85 REMARK 500 O GLU A 47 CB LEU A 50 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 128 CB CYS B 128 SG -0.116 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 62 N - CA - C ANGL. DEV. = 17.8 DEGREES REMARK 500 ARG B 217 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 217 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 ARG B 298 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -120.56 55.10 REMARK 500 LEU A 50 -127.88 55.28 REMARK 500 ASN A 84 -125.34 50.10 REMARK 500 TYR A 154 -120.70 51.21 REMARK 500 ALA A 191 40.62 -80.77 REMARK 500 ASP B 33 -130.06 45.08 REMARK 500 ASN B 84 -123.99 52.02 REMARK 500 ARG B 217 14.66 -140.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 49 LEU A 50 85.24 REMARK 500 LYS A 61 SER A 62 122.50 REMARK 500 ALA A 173 GLY A 174 -127.81 REMARK 500 ASN A 277 GLY A 278 -49.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 739 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH B 853 DISTANCE = 7.21 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WR1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WR1 B 602 DBREF 2OP9 A 1 301 UNP P59641 R1AB_CVHSA 3241 3541 DBREF 2OP9 B 1 301 UNP P59641 R1AB_CVHSA 3241 3541 SEQADV 2OP9 ALA A 0 UNP P59641 CLONING ARTIFACT SEQADV 2OP9 ALA B 0 UNP P59641 CLONING ARTIFACT SEQRES 1 A 302 ALA SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS SEQRES 2 A 302 VAL GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR SEQRES 3 A 302 THR LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS SEQRES 4 A 302 PRO ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN SEQRES 5 A 302 PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SEQRES 6 A 302 SER PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL SEQRES 7 A 302 ILE GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS SEQRES 8 A 302 VAL ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE SEQRES 9 A 302 VAL ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA SEQRES 10 A 302 CYS TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA SEQRES 11 A 302 MET ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN SEQRES 12 A 302 GLY SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP SEQRES 13 A 302 CYS VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO SEQRES 14 A 302 THR GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE SEQRES 15 A 302 TYR GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA SEQRES 16 A 302 GLY THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP SEQRES 17 A 302 LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU SEQRES 18 A 302 ASN ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL SEQRES 19 A 302 ALA MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS SEQRES 20 A 302 VAL ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE SEQRES 21 A 302 ALA VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU SEQRES 22 A 302 GLN ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR SEQRES 23 A 302 ILE LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG SEQRES 24 A 302 GLN CYS SER SEQRES 1 B 302 ALA SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS SEQRES 2 B 302 VAL GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR SEQRES 3 B 302 THR LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS SEQRES 4 B 302 PRO ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN SEQRES 5 B 302 PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SEQRES 6 B 302 SER PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL SEQRES 7 B 302 ILE GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS SEQRES 8 B 302 VAL ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE SEQRES 9 B 302 VAL ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA SEQRES 10 B 302 CYS TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA SEQRES 11 B 302 MET ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN SEQRES 12 B 302 GLY SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP SEQRES 13 B 302 CYS VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO SEQRES 14 B 302 THR GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE SEQRES 15 B 302 TYR GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA SEQRES 16 B 302 GLY THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP SEQRES 17 B 302 LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU SEQRES 18 B 302 ASN ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL SEQRES 19 B 302 ALA MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS SEQRES 20 B 302 VAL ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE SEQRES 21 B 302 ALA VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU SEQRES 22 B 302 GLN ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR SEQRES 23 B 302 ILE LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG SEQRES 24 B 302 GLN CYS SER HET WR1 A 601 29 HET WR1 B 602 29 HETNAM WR1 NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1- HETNAM 2 WR1 METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE FORMUL 3 WR1 2(C22 H26 N2 O5) FORMUL 5 HOH *491(H2 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 CYS A 44 5 4 HELIX 3 3 THR A 45 LEU A 50 1 6 HELIX 4 4 ASN A 53 ARG A 60 1 8 HELIX 5 5 SER A 62 HIS A 64 5 3 HELIX 6 6 ILE A 200 ASN A 214 1 15 HELIX 7 7 THR A 226 MET A 235 1 10 HELIX 8 8 LYS A 236 ASN A 238 5 3 HELIX 9 9 THR A 243 LEU A 250 1 8 HELIX 10 10 LEU A 250 GLY A 258 1 9 HELIX 11 11 ALA A 260 GLY A 275 1 16 HELIX 12 12 THR A 292 SER A 301 1 10 HELIX 13 13 SER B 10 GLY B 15 1 6 HELIX 14 14 HIS B 41 THR B 45 5 5 HELIX 15 15 GLU B 47 LEU B 50 5 4 HELIX 16 16 ASN B 53 ARG B 60 1 8 HELIX 17 17 SER B 62 HIS B 64 5 3 HELIX 18 18 ILE B 200 ASN B 214 1 15 HELIX 19 19 THR B 226 TYR B 237 1 12 HELIX 20 20 THR B 243 LEU B 250 1 8 HELIX 21 21 LEU B 250 GLY B 258 1 9 HELIX 22 22 ALA B 260 GLY B 275 1 16 HELIX 23 23 THR B 292 SER B 301 1 10 SHEET 1 A 7 VAL A 73 LEU A 75 0 SHEET 2 A 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 A 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 A 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 A 7 LEU A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 A 7 VAL A 77 GLN A 83 -1 N SER A 81 O ARG A 88 SHEET 1 B 5 LYS A 100 PHE A 103 0 SHEET 2 B 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 B 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 B 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 B 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 C 3 LYS A 100 PHE A 103 0 SHEET 2 C 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 C 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 D 7 VAL B 73 LEU B 75 0 SHEET 2 D 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 D 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 D 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 D 7 THR B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 LEU B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 D 7 VAL B 77 GLN B 83 -1 N SER B 81 O ARG B 88 SHEET 1 E 5 TYR B 101 PHE B 103 0 SHEET 2 E 5 VAL B 157 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 E 5 VAL B 148 ILE B 152 -1 N ASN B 151 O SER B 158 SHEET 4 E 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 E 5 SER B 121 ALA B 129 -1 O TYR B 126 N VAL B 114 SHEET 1 F 3 TYR B 101 PHE B 103 0 SHEET 2 F 3 VAL B 157 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 F 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 SITE 1 AC1 11 HIS A 41 MET A 49 LEU A 141 ASN A 142 SITE 2 AC1 11 GLY A 143 SER A 144 CYS A 145 MET A 165 SITE 3 AC1 11 GLU A 166 ARG A 188 HOH A 602 SITE 1 AC2 12 ALA A 0 HIS B 41 MET B 49 LEU B 141 SITE 2 AC2 12 GLY B 143 SER B 144 CYS B 145 MET B 165 SITE 3 AC2 12 GLU B 166 ASP B 187 ARG B 188 HOH B 603 CRYST1 52.314 96.798 67.877 90.00 103.20 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019115 0.000000 0.004483 0.00000 SCALE2 0.000000 0.010331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015132 0.00000